Supply Chain
Following major price increases, use of the two cardiac medicines has dramatically decreased at 47 hospitals, according to new research.
New York City Health and Hospitals plans to save close to $140 million by finding value across the spectrum.
Biosimilars have the potential to reduce the cost of treatment, but the savings are not realized for most providers.
Expert Julie Hurley will address pitfalls in "Securing and Illuminating the Pharmaceutical Supply Chain" webinar Wednesday.
Value-based agreements are increasing between health insurers and pharmaceutical manufacturers.
PBM says it is owed the money for an injectable drug used to combat opioid overdose.
Leapfrog Group says 30 percent of hospitals fully meet the four criteria for bar code medication administration, though 74 percent meet the group's two CPOE criteria.
Leaders consistently included shortages and drug pricing among their top concerns in the survey over the last two years.
Hospitals, doctors' practices, government, insurers, and healthcare IT companies could all be affected, Kalorama says.
From sample of 1,202 adults, eight percent of respondents said they or someone in their household had imported a drug at some point.